Assignee
SYNAPHARM IND SYNTHESIS
BE·2 granted patents·2 pending applications·0 citations·filing 2018–2021
Top patents by PatentIndex Score
4 records- 0144US2022008455A1Compound and Composition for Use in the Preventive and/or Curative Treatment of Diseases of the Central Nervous System Characterised by a Decline in Neuronal Plasticity, in Particular Characterised by a Decline in Synaptic PlasticitySYNAPHARM IND SYNTHESIS·Filed 2021·Application pending·0 cites
- 0239US12383520B2Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorderSYNAPHARM IND SYNTHESIS·Filed 2020·Granted Aug 12, 2025·0 cites·18 claims
- 0339US2020237812A1Compound and Composition for Use in the Preventive and/or Curative Treatment of Diseases of the Central Nervous System Characterised by a Decline in Neuronal Plasticity, in Particular Characterised by a Decline in Synaptic PlasticitySYNAPHARM IND SYNTHESIS·Filed 2018·Application pending·0 cites
- 0435US11053194B2Production process for magnesium N-acetyl taurinateSYNAPHARM IND SYNTHESIS·Filed 2020·Granted Jul 6, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when SYNAPHARM IND SYNTHESIS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →